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Background: Retroviral sequences 90-95% homologous to the mouse mammary tumor virus (MMTV) were present
in 38% of the breast cancers studied from American women and were not detectable in non-tumor breast tissue
from the same patient. The entire proviral structure was described and viral particles were isolated from primary
cultures of human breast cancer. This virus was designated as human mammary tumor virus (HMTV). Hormone
response elements present in the HMTV Long-Terminal-Repeat (LTR) suggest a mechanism for association of
HMTV with hormonally responding tissues. In fact, the incidence of HMTV sequences is higher in gestational
breast cancers, which are associated with hormonal changes. Milk epithelial cells are also under hormonal
regulation and therefore are excellent specimens for HMTV sequence detection.
Methods: The HMTV sequence was studied in milk samples from lactating women recruited with increased risk of
breast cancer because they had undergone breast biopsies (Biopsy-Group) and lactating women without breast
biopsies (Reference-Group).
Results: HMTV-env sequences were detected by PCR in milk of 7.61% of 92 women of the Reference-Group and in
20.55% of 73 women of the Biopsy-Group (p: 0.015). The sequences were 94-98% homologous to MMTV. HMTV-env
and HMTV-env/LTR junction sequences were detected in high-speed pellet RNA, implying the presence of HMTV
viral particles. PCR assays to detect the murine mitochondrial cytochrome oxidase gene and intracisternal-A-type
particle sequences were performed to rule out mouse mitochondrial or genomic DNA contamination. Eight women
of the 73 Biopsy-Group participants had breast cancer and the milk of only one of these eight women had
HMTV-env sequences. In the remaining 65 women of the Biopsy-Group, under enough clinical suspicion to lead
to biopsy, HMTV was detected in 14, nearly three times the number of milks as compared to the Reference-Group
(21.54% versus 7.61%; p: 0.016).
Conclusion: The significance of HMTV in milk from the Reference-Group, the greater frequency in the milk of women
who had undergone a breast biopsy and its possible infectivity for infants are important questions under study. The
similarity of HMTV to MMTV is striking and suggests one possible avenue for viral transmission in humans.
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Table 1 Presence of HMTV-env sequences in human milk
genomic DNA (P1)
Group Number of women env sequences % P*
Reference 92 7 7.61 -
Biopsied 73 15 20.55 0.015
*The chi-square test was used to compare the two groups.
Nartey et al. Infectious Agents and Cancer 2014, 9:20 Page 2 of 8
http://www.infectagentscancer.com/content/9/1/20Background
The presence of viral particles with the morphological
characteristics of betaretroviruses was first described in
human milk by Feller and Chopra [1,2]. In 1971 Moore
et al. [3] also described a betaretrovirus similar to mouse
mammary tumor virus (MMTV) in the milk from 5% of
American women with no familial history of breast can-
cer, 60% of American women with familial breast cancer
and 39% from Parsi women [3], who have a three-fold
greater risk of developing breast cancer than the non-
Parsi population in Bombay [3]. Schlom et al. (1972) [4]
found Reverse Transcriptase (RT) activity and RNA in
viral particles of the same density as that of betaretro-
viruses in human milk. A human protein related to the
envelope protein (Env) of MMTV was identified from a
pool of human milk samples from 300 healthy women [5].
Furthermore, another retroviral protein, p27, related to
MMTV gag gene was also shown to be present in some
established breast cancer cell lines and in cells from
human milk [6,7]. When human endogenous retroviruses
(HERV) with homology to MMTV were described in
the 1980’s, it was assumed that the particles described
above were endogenous in origin [8]. However, the pres-
ence of several other viruses in milk has now been studied
[9,10] and a recent report indicated that MMTV-like se-
quences were present in DNA of milk cells of 5% of
healthy Australian Women [11].
We have reported previously the presence of sequences
from a retrovirus 90-95% homologous to MMTV in 38-
40% of the breast cancers studied in American women
[12], whereas these sequences are not detectable in non-
tumor mammary tissue from the same breast that
contained the tumor [13]. The whole proviral structure has
been described and designated as human mammary tumor
virus (HMTV) [14]. The presence in human breast cancer
of sequences homologous to MMTV has been confirmed
by several groups [15-19]. Other authors have designated
these sequences as MMTV-like, and thus appear to be the
same virus as HMTV [15-19].
HMTV retroviral particles have been isolated from
primary cultures of human metastatic breast cancer cells
[20] and expression of HMTV proteins has been shown
in cells containing HMTV proviral DNA sequences [21].
We have also found that the incidence of HMTV
sequences is higher in inflammatory [22] and gestational
breast cancers than in sporadic specimens [23]. Gesta-
tional breast cancers, by definition, are associated with
major hormonal changes and hormone responsive
elements present in the LTR of HMTV [23], together
suggest a molecular mechanism to explain viral associ-
ation with hormonally responding tissues. Epithelial cells
from milk, because of their association with hormonal
changes, are excellent specimens in which to search for
HMTV sequences.In this communication we show that HMTV-env
sequences are present in the DNA of milk cells from
20.55% of the women who had previously undergone
breast biopsies as compared to only 7.61% of the women
in the Reference-Group. In addition, the detection of
HMTV-env/LTR junction sequences from the high-
speed pellet RNA indicates the presence of HMTV viral
particles in several milk samples of Biopsy and
Reference-Group women.
Results and discussion
Milk samples from 97 women in the Reference-Group
and 79 women in the Biopsy-Group were analyzed. The
β-globin gene could be amplified in milk samples from
92 of the 97 women in the Reference-Group and 74 of
the 79 women in the Biopsy-Group and thus they were
qualified for further analysis. All the DNA samples
showing presence of viral sequences were tested for the
presence of murine mitochondrial cytochrome oxidase
gene (MoMt) and murine intracisternal A-particles
(IAP) by PCR. Only one sample in the Biopsy-Group
was found to contain murine DNA and was eliminated
from future study.
The results (Table 1) indicated that HMTV-env was de-
tected in the DNA of 7 of 92 (7.61%) Reference-Group
women. For the Biopsy-Group, 15 of the 73 women
(20.55%) had HMTV sequences in the DNA of their milk
cells. This difference between both groups was statistically
significant (p: 0.015). The higher percentage of women
with HMTV sequences in their breast milk DNA was not
correlated with any of the demographic parameters previ-
ously examined including age at time of milk donation,
time after delivery, number of live births, or age at first
pregnancy [24,25]. Eight women in the Biopsy-Group
were diagnosed with breast cancer and one of them was
found to have HMTV sequences in her milk cell DNA.
Fourteen of the 65 (21.54%) biopsied women without
breast cancer had HMTV-env sequences in their milk.
One representative experiment is shown in Figure 1.
When HMTV-env amplicon sequences were compared
to MMTV (GenBank: M15122) sequences reported in the
GenBank they were found to be 94 to 98% homologous.
No major differences were found between HMTV
sequences isolated from the women in either group. The
HMTV-env sequence was submitted to the GenBank.
HMTV particle sequences were also sought in the
high-speed pellet (P2) RNA from milk of the same
Figure 1 Detection of HMTV-env gene sequences in milk cells. PCR was performed using primers 5 L and 3 L and nested PCR using primers 1XXX
and 3 F as described in Methods. A. Diagram of HMTV proviral DNA structure and location of the primers. B. HMTV-env DNA sequence using primers
1XXX and 3 F in a nested PCR reaction (GenBank KJ831809). C. 2% agarose gel electrophoresis of HMTV-env 251 bp amplicon. Lane 1: HMTV-env positive
sample, Lane 2: HMTV-env positive control, Lane 3: 1 kb plus DNA ladder. Southern blot hybridization using 32P labeled probe as described in Methods.
Lane 4: HMTV-env positive sample. Lane 5: HMTV-env positive DNA control.
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had HMTV sequences. RNA was extracted as described in
Methods and RT-PCR carried out for HMTV-env (Figure 2)
and HMTV-env/LTR junction sequences (Figure 3). The
HMTV sequences from the cDNA were compared to
sequences present in the GenBank. HMTV-env sequences
were 94 to 98% homologous to MMTV (GenBank:
M15122) and HMTV-env/LTR junction sequence was 96%Figure 2 Detection of HMTV-env gene sequences in P2 RNA. cDNA syn
was performed using primers 5 L and 3 L and nested PCR using primers 1X
structure and location of the primers. B. HMTV-env cDNA sequence was am
KJ831810). C. 2% agarose gel electrophoresis of HMTV-env 251 bp amplicon
Lane 3: Southern blot hybridization using 32P end labeled probe for HMTV-homologous to MMTV (GenBank: M15122). Results in
Table 2 indicate that HMTV-env and HMTV-env/LTR
junction sequences were amplified from P2 RNA when the
HMTV-env also was detected in the genomic DNAs from
P1. HMTV-env sequences were amplified in P2 RNA from
2 out of 3 women of the Reference-Group. All three of
these women also had HMTV sequences detected in their
genomic DNA and HMTV-env/LTR junction sequencesthesized from high speed pellet (P2) RNA using polydT as primer, PCR
XX and 3 F as described in Methods. A. Diagram of HMTV viral RNA
plified using primers 1XXX and 3 F in a nested PCR reaction (GenBank
. Lane 1: HMTV-env positive sample. Lane 2: 1 kb plus DNA ladder.
env positive sample.
Figure 3 Detection of HMTV-env/LTR junction sequences in P2 RNA. cDNA synthesized from high speed pellet (P2) RNA using primer LTR3
and PCR performed using primers ENV-3LR’, LTR-5MR and semi nested PCR with ENV-3LR’ and LTR-1R’ as described in Methods. A. Diagram of
HMTV viral RNA structure and location of the primers. B. Sequence amplified from cDNA using primers ENV-3LR’, LTR-5MR by PCR and by semi
nested PCR with ENV-3LR’ and LTR-1R’ primers (GenBank KJ831811). C. 1% agarose gel electrophoresis of HMTV-env/LTR 1018 bp amplicon. Lane 1:
HMTV-env/LTR positive cDNA sample. Lane 2: 1 kb plus DNA ladder. Lane 3: Southern blot hybridization using
32P end labeled probe for HMTV-env/LTR
positive cDNA sample.
Nartey et al. Infectious Agents and Cancer 2014, 9:20 Page 4 of 8
http://www.infectagentscancer.com/content/9/1/20present in P2 RNA. In the case of the Biopsied-Group,
HMTV-env and HMTV env/LTR junction sequences were
amplified in P2 RNA from 4 out of 5 women whose gen-
omic DNA contained HMTV sequences. HMTV-env/LTR
junction sequences were detected in a total of 7 P2 RNA
samples of which one contained enough material to allow
sequencing. HMTV-env and env/LTR junction sequences
from P2 RNA have been submitted to the GenBank.
Absence of glycerol-3-phosphate dehydrogenase gene
(G3DPH) mRNA from high-speed pellets and the presence
of HMTV-env/LTR junction sequences is consistent with
the presence of virion RNA.
During lactation, the mammary gland undergoes
molecular changes in response to hormonal influences.
Gestational breast cancer that develops during preg-
nancy or lactation is considered to be very aggressive
and related to hormonal changes, and it has been shown
to have a high incidence of viral HMTV sequences [23].
In this communication evidence is presented that milk
cells of 7.61% of women from a Reference-Group contain
HMTV viral sequences in their genomic DNA. The per-
centage of women with HMTV sequences in the milk cells
from the Biopsy-Group is remarkably higher (20.55%).
The usual indications for biopsy are physical, radiologic,Table 2 Detection of HMTV sequences in human milk high sp
Group HMTV-env sequences in genomic DNA (P1) HMTV-env seq
Reference 3
Biopsied 5or sonographic findings, which raise the possibility of
breast cancer [26]. According to the American Cancer
Society, roughly one out of five breast biopsies results in a
diagnosis of cancer [26]. Eight of the women in the
Biopsy-Group were found to have breast cancer and one
of the eight had HMTV sequences in her milk. Of the
remaining 65 women of the Biopsy-Group, under enough
clinical suspicion to lead to biopsy, 21.54% contain HMTV
sequences in their milks. This percentage represents a
nearly three-fold increase compared to the Reference-
Group women (p: 0.016). This finding suggests that the
presence of the HMTV sequences is associated with
increased breast cancer risk.
The present results confirm, extend, and validate the
findings of the 1960s and 1970s that provided morpho-
logical and immunologic evidence of viral particles similar
to MMTV in human milk [1-4]. These results are in agree-
ment with the observations of Johal et al. [11] that env se-
quences are present in the milks from 5% of Australian
healthy women. We have proven that the sequences are
not derived from murine contamination, and add the strik-
ing observation that clinical findings that led to a biopsy
were associated with a nearly 3-fold increase in women
who had HMTV sequences in their milk. Furthermore, weeed Pellet P2 RNA
uences in RNA (P2) HMTV-env/LTR junction sequences in RNA (P2)
2/3 3/3
4/5 4/5
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sequences in the high-speed pellet RNA from milk super-
natants, which is consistent with the presence of viral
particles.
Conclusion
The significance of HMTV in human milk, its greater fre-
quency in the milk of women who have undergone a
breast biopsy and its possible transmission to their infants,
are important questions still under study. The similarity of
HMTV and MMTV in this regard is striking and suggests
one possible avenue for human transmission.
Breastfeeding in general has been considered to lower
the risk of eventual breast cancer in the offspring [27].
However, nearly all infants have been exposed to colos-
trum, even when mothers deny having breastfed their chil-
dren [11,28,29]. Therefore, a small proportion of breastfed
infants who might have been at increased risk may have
been hidden in the data. The results presented here pave
the way to stimulate research in this area and to develop
strategies that are precisely targeted to prevent transmis-
sion by HMTV carrying women, without eliminating the
well-known benefits of breastfeeding for those who do not
carry the virus. Such attempts have been very successful
in Japan, where HTLV, the causative agent of adult T-cell
leukemia, has been significantly reduced in the population




Milk samples were provided by K. F. Arcaro at the
University of Massachusetts at Amherst, MA. Collection
was performed with the women’s consent, following the
conditions approved by the institutional review board (IRB)
of the University of Massachusetts-Amherst as described in
previous publications [24,25]. Milk from two groups of
American women was studied. One group, referred to as
the Reference-Group, involved nursing women without bi-
opsies. The other group, referred to as the Biopsy-Group,
consisted of nursing women from across the US who ei-
ther had undergone a breast biopsy at some point in their
lives or were scheduled to have a breast biopsy. The
Biopsy-Group represents women whose clinical or radio-
logical findings suggested the need for a biopsy to exclude
breast cancer and are thus considered to be at increased
risk of breast cancer [25]. Frozen milks were sent on dry
ice to B. G-T Pogo. For each of 97 women in the
Reference-Group, a single sample (80 to 120 ml) of milk
was received. For 60 women in the Biopsy-Group matched
samples (80 to 120 ml) of milk from the left and right
breasts were received along with a single sample of similar
volume from either the left or right breasts of an add-
itional 19 women. Thus a total of 139 samples from 79women was received from the Biopsy-Group. Milks were
kept frozen at -20°C until processing. The milk samples
were first centrifuged at 1,000 × g for 30 minutes at 4°C.
The fat layer was removed and supernatant designated
S1 transferred to a new tube and the resulting cell pellet
(P1) was re-suspended in PBS and DNA was extracted.
The supernatant was then centrifuged at 10,000 × g for
30 min. and the resulting supernatant was centrifuged at
100,000 × g for 150 min at 4°C. This high-speed pellet
designated as P2 was stored at −80°C.DNA extraction
DNA from P1 was extracted according to the manufac-
turer’s instructions (Life Technology Inc., Carlsbad, CA).
The suitability of DNAs for PCR was tested by amplifying
a 250 bp sequence of the β-globin gene using primers GH-
20 (5′GAAGAGCCAAGGACAGGTAC-3′) and PCO4 (5′
CAACTTCATCCACGTTCACC-3′) under the conditions
previously described [31]. β-globin sequences were ampli-
fied in all reported specimens.Detection of HMTV-env sequences
PCRs were performed on 250 ng of DNA using Illustra
PureTaq Ready-To-Go PCR beads (GE Healthcare Inc.,
Piscataway, NJ) and 10 pmol of the following primers
5 L (5′-CCAGATCGCCTTTAAGAAGG-3′) and 3 L (5′-
TACAGGTAGCAGCACGTATG-3′). The amplicon prod-
uct was 595 bp. A nested PCR was then performed with
the primers 1XXX (5′-ACTGCACTAGTCCCCCATAC-
3′) and 3 F′ (5′-ATCGCTGCATAGTCGTAGGC-3′). The
product is 251 bp. Both HMTV-env PCR reactions were
performed in a thermocycler under the following condi-
tions [32] with minimal modifications: a cycle of 95°C for
5 min, followed by 35 cycles of 95°C for 30 sec, 58°C for
30 sec, 72°C for 30 sec, and a final step of 72°C for 7 min.
Each sample was tested three times to assure the reproduci-
bility of the reaction. In addition, several reactions without
template DNA were performed, along with the experimen-
tal reactions, to rule out possible contamination of the
nuclease-free sterile water and primers.
To identify the amplicon, the gel was transferred onto a
positively charged nylon membrane (GE Healthcare Inc.,
Piscataway, NJ) by capillary action and hybridized with
32P-labeled oligonucleotide 1XXXX probe (5′-AGGCCAG
GATTTCAAGAACA-3′). The probe was radiolabeled by
the end terminal labeling method (New England Biolabs,
Ipswich, MA).
After the band was identified by hybridization the
remaining PCR product was amplified using the same
nested primers and again run in an agarose gel. The
nested PCR product (251 bp) was removed from the gel,
purified following the conditions recommended by the
manufacturer of QIAQuick Gel Extraction Kit (Qiagen
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Mount Sinai Genomics Institute Sequencing core facility.
RNA extraction
RNA was extracted from the 100,000 × g pellet (P2) using
Trizol LS Reagent following the manufacturer′s protocol
(Life Technologies, Carlsbad, CA). RNA samples were
treated with DNAse and the absence of DNA was con-
firmed by failing to detect the G3DPH gene sequence by
PCR using GE Healthcare Illustra PureTaq Ready To Go
PCR Beads, (GE Healthcare, Piscataway NJ), 10 pmol of
primers: G3DPH-3 (5′-GGTGAAGACGCCAGTGGACT
C-3′), and G3DPH-5 (5′-GTGAAGGTCGGAGTCAACG
GA-3′) and the conditions previously described [20].
cDNA preparation
Two sets of cDNA were synthetized using the same P2
RNA samples. One set of cDNA synthesized with oligo-
dt was used for the detection of G3DPH and HMTV-
env and the other set with LTR3 primer was used for the
detection of HMTV-env/LTR junction sequences.
Oligo-dt cDNA synthesis
Oligo-dt cDNA was obtained using 2 ug of RNA, oligo-dt
primer (Thermo Fisher Scientific, Pittsburgh, PA), and
RNaseOut (Life Technologies, Grand Island, NY) follow-
ing the protocol of the Omniscript Reverse Transcription
Kit (Qiagen Inc., Valencia, CA) [20].
Detection of HMTV-env/LTR junction sequences
cDNA from HMTV-LTR (LTR3 cDNA) was obtained using
2 µg of P2 RNA, LTR3 primer (5′-CGAACAGACACAAA-
CACACG-3′), and RNaseOut following the protocol of the
Qiagen Omniscript Reverse Transcription Kit [20].
HMTV-env/LTR junction sequences were detected in
the LTR3 cDNA by PCR using 10 pmol of primers LTR-
5MR (5′-ATAAGTCCCTGGTTGCCACC-3′) and ENV-
3LR′ (5′-CATATGTGCTGCTACCTGTA-3′), 250 ng of
cDNA and the Advantage 2 PCR Kit (Clontech Laborator-
ies, Inc., Mountain View, CA) under the following condi-
tions: 95°C for 1 min, 35 cycles of 95°C for 30 sec, 62°C
for 1 min, 68°C for 1 min, and finally a cycle of 68°C for
10 min. The expected amplicon was 1378 bp. A semi-
nested PCR was then performed with the primers ENV-
3LR′ and LTR-1R′ (5′-TCAGGAGGAAGGTCGAGT
TCT-3′) under the following conditions: 95°C for 1 min,
35 cycles of 95°C for 30 sec, 62°C for 1 min, 68°C for
1 min, and finally a cycle of 68°C for 10 min [20]. The
product was 1018 bp. Each sample was tested three times
to assure the reproducibility of the reaction. In addition,
several reactions without template DNA were performed,
along with the experimental reactions, to rule out possible
contamination of the nuclease-free sterile water and
primers. To identify the amplicon, the gel was thentransferred and hybridized with a 32P-labeled oligonucleo-
tide env/LTR probe (5′-CTGCAGCAGAAATGGTTGA
A-3′) [20].
After amplicons were detected on film, the remaining
PCR products were re-amplified using the same primers.
The amplified PCR product was run in a 1% agarose gel,
isolated and purified using the Quick Gel Extraction Kit
and submitted for sequencing at the Mount Sinai Genomics
Institute Sequencing facility. The sequences were compared
to sequences present in the GenBank. All procedures were
carried out in a laminar flow hood based in a laboratory
with exclusive use for human tissues.
Detection of murine DNA
Although the experiments were performed in a room re-
stricted to human tissue work, a series of PCRs were done
to detect mouse DNA contamination in any human DNA
in which HMTV sequences were detected. Two assays
were used to detect murine contaminant DNA [32].
One of these assays is for the detection of cytochrome
oxidase, a gene that is part of MoMt [32]. To test for
MoMt, the following primers were used: mt15982F
(5′- AGACGCACCTACGGTGAAGA-3′) and mt16267R
(5′-AGAGTTTTGGTTCACGGAACATGA-3′) [32]. The
product yields an amplicon of 286 bp. A semi-nested
PCR was then performed using the primers mt16115F
(5′-TGCCAAACCCCAAAAACACT-3′) and mt16267R,
which results in a 153 bp amplicon [32]. The PCR product
was transferred from the gel to a positively charged nylon
membrane and hybridized with a 32P-labeled oligonucleo-
tide MoMt DNA probe (5′-GAACTAGAATTGATCAGG
CAT-3′). The sensitivity of this reaction has been improved
by the hybridization step and is 1.25 fg.
The other assay is for the detection of IAP. IAP are
retrotransposon elements present at the level of about
1000 copies of varying length per mouse genome. IAP
PCR has been proposed as an assay for the detection of
murine DNA contamination of human DNA specimens
[33]. Amplification of the IAP sequences from the mouse
genome by PCR was carried out using the following
primers: forward primer (5′-ATAATCTGCGCATGAGC
CAAGG-3′) and reverse primer (5′-AGGAAGAACAC
CACAGACCAGA-3) under the recommended conditions
[33]: one cycle of 95°C, 5 minutes, 35 cycles of 95°C 30
seconds, 58°C 30 seconds, 72°C 20 seconds and one cycle
of 72°C, 7 minutes. Products of variable size, reflecting
diversity of the IAP, were visualized in a 2% ethidium
bromide stained agarose gel [33]. The sensitivity of this re-
action is 1.25 pg.
Statistical analysis
Statistical analysis was performed using a Chi-square test
to determine the association of the presence of HMTV
sequences in the DNA of milk cells from the women of
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introduce multivariate control for other possible differ-
ences between Biopsy and Reference Groups. However,
other covariates were also examined in bivariate tests
(which adjusted for sample clustering differences be-
tween the two groups of subjects when necessary) and
were not found to be significantly associated with the
presence of HMTV sequences.
Abbreviations
MMTV: Mouse mammary tumor virus; HMTV: Human mammary tumor virus;
LTR: Long-Terminal-Repeat; Env: Envelope; PCR: Polymerase chain reaction;
RT: Reverse transcriptase; HERV: Human endogenous retrovirus;
MoMt: Murine mitochondrial DNA; IAP: Intracisternal-A-type particles;
G3PDH: Glycerol-3-phosphate dehydrogenase; HTLV: Human T cell leukemia
virus; IRB: Internal review board.
Competing interests
The authors declare no competing interest.
Authors’ contributions
TN, HM and TM performed the laboratory experiments; KFA was responsible
for supplying the milk specimens. DLA carried out the statistical analysis;
SMM and BGTP designed the experiments and supervised the experiments.
SMM, BGTP, PE and JFH were involved with the writing of manuscript. All
authors read and approved the manuscript.
Acknowledgements
Supported in part by the Avon Foundation (BG-TP, KFA), the TJ Martell
Foundation for Leukemia, Cancer, and AIDS Research (TN, TM, HM, SMM, JFH,
BG-TP), the Ruttenberg Family Foundation, the Faith Lynn Kash Foundation,
and the Myra Shaw Cancer Fund. James F. Holland serves as an
uncompensated consultant and as a member of the National Medical
Advisory Board of the T.J. Martell Foundation.
Author details
1The Tisch Cancer Institute and Department of Medicine, Icahn School of
Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.
2Department of Veterinary and Animal Sciences, University of Massachusetts
at Amherst, 240 Thatcher Road, Amherst, MA 01003, USA. 3Department of
Sociology, Sloan College, University of South Carolina, Rm 321. 911 Pickens
St., Columbia, SC 29208, USA. 4Department of Microbiology, Icahn School of
Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.
Received: 19 March 2014 Accepted: 12 May 2014
Published: 17 June 2014
References
1. Feller WF, Chopra HC: Studies of human milk in relation to the possible
viral etiology of breast cancer. Cancer 1969, 24(6):1250–1254. PMID:
4311119.
2. Feller WF, Chopra HC: Virus-like particles in human milk. Cancer 1971,
28(6):1425–1430. PMID: 5001818.
3. Moore DH, Charney J, Kramarsky B, Lasfargues EY, Sarkar NH, Brennan MJ,
Burrows JH, Sirsat SM, Paymaster JC, Vaidya AB: Search for a human breast
cancer virus. Nature 1971, 229(5287):611–614. PMID: 4925461.
4. Schlom J, Spiegelman S, Moore DH: Detection of high-molecular-weight
RNA in particles from human milk. Science 1972,
175(4021):542–544. PMID: 4332822.
5. Dion AS, Farwell DC, Pomenti AA, Girardi AJ: A human protein related to
the major envelope protein of murine mammary tumor virus:
identification and characterization. Proc Natl Acad Sci USA 1980,
77(3):1301–1305. PMID: 6154929.
6. Litvinov SV, Golovkina TV: Expression of proteins immunologically related
to murine mammary tumour virus (MMTV) core proteins in the cells of
breast cancer continuous lines MCF-7, T47D, MDA-231 and cells from
human milk. Acta Virol 1989, 33(2):137–142. PMID: 2569809.
7. Litvinov SV, Golovkina TV, Kriukova IN, Vasilevskaia LN: A protein related to
the main core protein of the mouse mammary cancer virus in amicroparticle fraction of human milk. Biull Eksp Biol Med 1987,
103(3):338–340. PMID: 3030463.
8. Westley B, May FE: The human genome contains multiple sequences of
varying homology to mouse mammary tumour virus DNA. Gene 1984,
28(2):221–227. PMID: 6329918.
9. Glenn WK, Whitaker NJ, Lawson JS: High risk human papillomavirus and
Epstein Barr virus in human breast milk. BMC Res Notes 2012,
5:477. PMID: 22937830.
10. Pillay K, Coutsoudis A, York D, Kuhn L, Coovadia HM: Cell-free virus in
breast milk of HIV-1- seropositive women. J Acquir Immune Defic
Syndr 2000, 24(4):330–336. PMID: 11015149.
11. Johal H, Ford C, Glenn W, Heads J, Lawson J, Rawlinson W: Mouse
mammary tumor like virus sequences in breast milk from healthy
lactating women. Breast Cancer Res Treat 2011, 129(1):149–155. PMID:
21365265.
12. Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, Cantarella A,
Stellrecht K, Mani S, Pogo BG: Detection of mammary tumor virus env
gene-like sequences in human breast cancer. Cancer Res 1995,
55(22):5173–5179. PMID: 7585568.
13. Melana SM, Holland JF, Pogo BG: Search for mouse mammary tumor
virus-like env sequences in cancer and normal breast from the same
individuals. Clin Cancer Res 2001, 7(2):283–284. PMID: 11234880.
14. Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG:
Identification of a proviral structure in human breast cancer.
Cancer Res 2001, 61(4):1754–1759. PMID: 11245493.
15. Etkind P, Du J, Khan A, Pilliteri J, Wiernik PH: Mouse mammary tumor
virus-like ENV gene sequences in human breast tumors and in a
lymphoma of a breast cancer patient. Clin Cancer Res 2000,
6(4):1273–1278. PMID: 10778951.
16. Ford CE, Tran D, Deng Y, Ta VT, Rawlinson WD, Lawson JS: Mouse mammary
tumor virus- like gene sequences in breast tumors of Australian and
Vietnamese women. Clin Cancer Res 2003, 9(3):1118–1120. PMID: 12631616.
17. Luo T, Wu XT, Zhang MM, Qian K: Study of mouse mammary tumor
virus-like gene sequences expressing in breast tumors of Chinese
women. Sichuan Da Xue Xue Bao Yi Xue Ban 2006, 37(6):844–846. 851.
PMID: 17236577.
18. Zammarchi F, Pistello M, Piersigilli A, Murr R, Di Cristofano C, Naccarato AG,
Bevilacqua G: MMTV-like sequences in human breast cancer: a
fluorescent PCR/laser microdissection approach. J Pathol 2006,
209(4):436–444. PMID: 16710841.
19. Zapata-Benavides P, Saavedra-Alonso S, Zamora-Avila D, Vargas-Rodarte C,
Barrera-Rodríguez R, Salinas-Silva J, Rodríguez-Padilla C, Tamez-Guerra R,
Trejo-Avila L: Mouse mammary tumor virus-like gene sequences in breast
cancer samples of Mexican women. Intervirology 2007, 50(6):402–407.
PMID: 17975321.
20. Melana SM, Nepomnaschy I, Sakalian M, Abbott A, Hasa J, Holland JF, Pogo BG:
Characterization of viral particles isolated from primary cultures of human
breast cancer cells. Cancer Res 2007, 67(18):8960–8965. PMID: 17875739.
21. Melana SM, Nepomnaschy I, Hasa J, Djougarian A, Djougarian A, Holland JF,
Pogo BG: Detection of human mammary tumor virus proteins in human
breast cancer cells. J Virol Methods 2010, 163(1):157–161. PMID: 19781575.
22. Pogo BG, Holland JF, Levine PH: Human mammary tumor virus in
inflammatory breast cancer. Cancer 2010, 116(11 Suppl):2741–2744. PMID:
20503403.
23. Wang Y, Melana SM, Baker B, Bleiweiss I, Fernandez-Cobo M, Mandeli JF,
Holland JF, Pogo BG: High prevalence of MMTV-like env gene sequences
in gestational breast cancer. Med Oncol 2003, 20(3):233–236. PMID:
14514972.
24. Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF:
Quantitative analysis of promoter methylation in exfoliated epithelial cells
isolated from breast milk of healthy women. Epigenetics 2010,
5(7):645–655. PMID: 20716965.
25. Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF:
Increased promoter methylation in exfoliated breast epithelial cells in
women with a previous breast biopsy. Epigenetics 2011, 6(12):1425–1435.
PMID: 22139572.
26. National Cancer Institute: www.cancer.gov/cancertopics/factsheet/
detection/probability-breast-cancer.
27. Potischman N, Troisi R: In-utero and early life exposures in relation to risk
of breast cancer. Cancer Causes Control 1999, 10(6):561–573. PMID:
10616825.
Nartey et al. Infectious Agents and Cancer 2014, 9:20 Page 8 of 8
http://www.infectagentscancer.com/content/9/1/2028. Lawson JS, Heads J, Glenn WK, Whitaker NJ: Breastfeeding, breast milk,
and viruses. BMC Womens Health 2007, 7:17. PMID: 17919341.
29. Lawson JS, Glenn WK, Salmons B, Ye Y, Heng B, Moody P, Johal H,
Rawlinson WD, Delprado W, Lutze-Mann L, Whitaker NJ: Mouse mammary
tumor virus-like sequences in human breast cancer. Cancer Res 2010,
70(9):3576–3585. PMID: 20388779.
30. Hino S: Establishment of the milk-borne transmission as a key factor for
the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1):
the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci
2011, 87(4):152–166. PMID: 21558754.
31. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J,
Manos MM: Detection and typing of human papillomavirus in archival
cervical cancer specimens by DNA amplification with consensus
primers. J Natl Cancer Inst 1990, 82(18):1477–1484. PMID: 2167986.
32. Deligdisch L, Marin T, Lee AT, Etkind P, Holland JF, Melana S, Pogo BG:
Human mammary tumor virus (HMTV) in endometrial carcinoma.
Int J Gynecol Cancer 2013, 23(8):1423–1428. 23873177.
33. Oakes B, Tai AK, Cingöz O, Henefield MH, Levine S, Coffin JM, Hubert BT:
Contamination of human DNA samples with mouse DNA can lead to
false detection of XMRV-like sequences. Retrovirology 2010, 7:109. PMID:
21171973.
34. Blair R, Taylor RA: Biostatistics for the Health Sciences. NJ: Pearson Education
Inc; 1993.
doi:10.1186/1750-9378-9-20
Cite this article as: Nartey et al.: Human Mammary Tumor Virus (HMTV)
sequences in human milk. Infectious Agents and Cancer 2014 9:20.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
